Publications by authors named "Jeremy Sen"

Claim this Profile
E
Evaluation of palonosetron, fosaprepitant, and olanzapine as antiemetic prophylaxis for fludarabine and melphalan-based conditioning regimens prior to allogeneic hematopoietic stem cell transplants.
Riley Karpen, Jeremy Sen, Sarah Wall, Samantha Musson, Justin Tossey

Leuk Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variant Acute Promyelocytic Leukemia Presenting Without Auer Rods Highlights the Need for Correlation with Cytogenetic Data in Leukemia Diagnosis.
Elizabeth L Courville, Lindsey Shantzer, Hans Christoph Vitzthum von Eckstaedt, Holly Mellot, Michael Keng, Jeremy Sen

Lab Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M Barlow

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gilteritinib: An FMS-like tyrosine kinase 3/AXL tyrosine kinase inhibitor for the treatment of relapsed or refractory acute myeloid leukemia patients.
Daniel R Reed, Jeremy M Sen, Eric J Pierce, Ramey Z Elsarrag, Michael K Keng

J Oncol Pharm Pract· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of cardiomyopathy in acute myeloid leukemia patients treated with anthracyclines.
Meredith K Mort, Jeremy M Sen, Amy L Morris, Kathlene A DeGregory, Erin M McLoughlin

J Oncol Pharm Pract· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Initiative to Reduce Mucosal Barrier Injuries and Bloodstream Infections in Patients With Hematologic Malignancy Receiving Inpatient Chemotherapy.
Daniel Reed, Jeremy Sen, Katie Lassiter, Tanya Thomas, Erin Harr

JCO Oncol Pract· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary Effort to Decrease Time From Admission to Chemotherapy on an Inpatient Oncology Unit.
Louise Man, Jeremy Sen, Jeanne Giordano, Erin McLoughlin, Amy Morris

J Oncol Pract· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate.
Daniel R Reed, Eric J Pierce, Jeremy M Sen, Michael K Keng

Cancer Manag Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Major Bleeding with Ibrutinib.
Joseph Mock, Paul R Kunk, Surabhi Palkimas, Jeremy M Sen, Michael Devitt

Clin Lymphoma Myeloma Leuk· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing an Antifungal Program to Reduce Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Receiving Induction and Reinduction Chemotherapy.
Amy L Morris, Mohammed Naeem, Torey Murray, Jeremy Sen, Tanya Thomas

J Oncol Pract· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date.
Lindsey Hathaway, Jeremy Michael Sen, Michael Keng

Patient Relat Outcome Meas· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible posterior leukoencephalopathy syndrome during regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors.
Zaw W Myint, Jeremy M Sen, Nicole L Watts, Thomas J Druzgal, Barnett R Nathan

Clin Colorectal Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts.
Mark D Walsh, Suzan K Hanna, Jeremy Sen, Sumit Rawal, Carolina B Cabral

Clin Cancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis